FILTER VISION PUBLIC COMPANY LIMITED Opportunity Day : Q1.2018 May - PowerPoint PPT Presentation

FILTER VISION PUBLIC COMPANY LIMITED Opportunity Day : Q1.2018 May 22, 2018 At The Stock Exchange of Thailand 1

Disclaimer  The information contained in this presentation is for information purposes only and does not constitute an offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for share in Filter Vision Public Company Limited (“FVC” and shares in FVC “shares”) in any jurisdiction nor should it or any part of it form the basis of, or be relied upon i n any connection with, any contract or commitment whatsoever.  This presentation may include information which is forward-looking in nature. Forward-looking information involve known and unknown risks, uncertainties and other factors which may impact on the actual outcomes, including economic conditions in the markets in which FVC operates and general achievement of FVC business forecasts, which will cause the actual results, performance or achievements of FVC to differ, perhaps materially, from the results, performance or achievements expressed or implied in this presentation.  This presentation has been prepared by FVC. The information in this presentation has not been independently verified. No representation, warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions in this presentation. None of FVC or any of its agents or advisers, or any of their respective affiliates, advisers or representatives, shall have any liability (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation.  This presentation is made, furnished and distributed for information purposes only. No part of this presentation shall be relied upon directly or indirectly for any investment decision-making or for any other purposes.  This presentation and all other information, materials or documents provided in connection therewith, shall not, either in whole or in part, be reproduced, redistributed or made available to any other person, save in strict compliance with all applicable laws. 2

Contents Business Overview Financial Information Strategy and Outlook Q & A 3

Contents Business Overview Financial Information Strategy and Outlook Q & A 4

Business Overview FVC distribute, design, assembly, install and preventive maintenance of water treatment system and related products Industrial & OEM Commercial & Residential Medical Service B3 B1 B2 B3 (IRV) – Dialysis SOL N , Water and Facility for Hemodialysis ( HD ) B3 ( KTMS) – Hemodialysis Center B3 (MV) – Pneumatic Tube System B3 (HHC) – Healthcare and aesthetics 5

Business Overview B1 : Industrial and OEM Semi Automatic Water Purifier Reverse Osmosis System Automatic Regenerate Softener Filter 6

Business Overview B1 : Industrial and OEM Zero Discharge Wastewater Treatment System Ultra Filtration 7

Business Overview B2 : Commercial and residential UV System Prefilter R30-BB+7FC Triple+Claris L 8

Business Overview B2 : Commercial and residential RO system + Everpure High flow triple Water system for drinking water and ice machine 9

Business Overview B3 : Medical service IRVING CORPORATION LIMITED Pure Water Treatment System for HD Decoration for HD 10

Business Overview B3 : Medical service IRVING CORPORATION LIMITED Chemical Hood Dialysate Solution Dialyzer Cabinet 11

Business Overview B3 : Medical service KT MEDICAL SERVICE COMPANY LIMITED KT Medical Service Hemodialysis Center 12

Business Overview B3 : Medical service MEDICAL VISION COMPANY LIMITED Pneumatic Tube System 13

Business Overview B3 : Medical service HI HEALTHCARE CENTER COMPANY LIMITED Healthcare and aesthetics clinic under trademark “ Wuttisak Clinic” 14

Customer Segments Industrial & OEM (B1) 15

Customer Segments Commercial & Residential (B2) 16

Customer Segments Commercial & Residential (B2) 17

Customer Segments Medical Service ( B3) 18

Content Business Overview Financial Information Strategy and Outlook Q & A 19

Financial Information Revenue Q1’18 Revenue Breakdown Bt. mil 459.26 500 394.31 B1 364.91 11% 400 360.75 B3 302.86 300 46% B2 43% 200 144.09 112.49 100 Q1’17 Revenue Breakdown 0 2013 2014 2015 2016 2017 Q1'17 Q1'18 B1 increase/ 18% (Bt.mil) Q1’2017 Q1’2018 % B3 decrease 31% B1 20.6 3 16.43 -4.20 -20.36 % B2 57.63 62.13 4.50 7.81% B2 B3 34.23 65.53 31.30 91.44% 51% 20 Total 112.49 144.09 31.60 28.09%

Financial Information Gross Profit Margin YoY -12.42% 31.64% 28.59% 28.10% 27.94% 27.21% 26.34% 15.68% 2013 2014 2015 2016 2017 Q1'17 Q1'18 Gross Profit Margin Gross profit margin decreased %, due to >> Some of revenue which increase has low margin. >> However, tend of revenue to increase continuously. 21

Financial Information SG&A Q1’18 SG&A Breakdown (Bt.mil) YoY Others 25.67 31.11 Professional 14% 21.19% 6% 27.37 25.67 26.19 27.72 7.64 Depreciation 5% 7.02 6.64 Office expense 6.65 6.53 6.53 5% Personnel 65% Traveling 5% 17.32 13.84 14.35 12.71 12.71 13.57 SG&A increased by 21.19 % : 6.89 6.43 6.35 6.43 5.97 6.15 Mainly from Personnel expenses and expenses of the new subsidiary. Q1'17 Q2'17 Q3'17 Q4'17 Q1'17 Q1'18 Selling Admin Management 22

Financial Information Net Profit & Net Profit Margin (Bt.mil) % 24.00 6.00% 5.06% 4.72% 5.06% YoY -9.43% 19.00 4.00% 2.88% 2.38% 14.00 2.00% AMOUNT 21.69 YoY 9.00 0.00% -210.72% 9.72 4.00 -2.00% 5.69 5.69 4.99 (1.00) -4.00% 1Q17 2Q17 3Q17 4Q17 Q1'17 Q1'18 -6.3 -4.37% (6.00) -6.00% Net Profit Net Profit Margin >> Revenue in new business has insufficient to cover the costs. >> Trend of sale and service income will grown as continues. 23

Financial Information Balance Sheet (Bt.mil) 900.00 Asset Equity Liabilities 800.00 177.77 123.43 700.00 600.00 500.00 835.17 787.13 107.94 400.00 657.40 663.70 70.72 300.00 466.93 407.05 71.96 76.97 358.99 336.33 275.40 285.95 200.00 208.98 203.44 100.00 2013 2014 2015 2016 2017 Q1'18 Assets >> Purchased assets amount 96.18 MB ( from assets agreement amount 66.17 MB. ). >> Account receivable in new business as increase amount 36.70 MB. >> Inventory in new business as increased amount 28.39 MB. >> Cash and cash equivalent decrease amount 130.34 MB. >> Account payable and unearned income in new business amounting 26.43 MB. Liabilities >> Loan from financial institute amount 24.18 MB. 24

Financial Information ROA 4.89% QoQ YoY >> Investing in -6.57% 3.46% 0.78% 3.46% franchise cannot 2.17% 1.67% generate a good return in short term. 1Q17 2Q17 3Q17 4Q17 4Q17 1Q18 -3.11% ROE 6.29% QoQ 4.24% 4.24% -8.06% 2.60% 2.01% 1Q17 2Q17 3Q17 4Q17 4Q17 1Q18 -3.82% 25

Financial Information D/E QoQ 0.08% 0.27 0.27 0.19 0.19 0.14 0.14 1Q17 2Q17 3Q17 4Q17 4Q17 1Q18 D/E ratio increased from previous year, due to >> Loan from financial institute amount 24.18 MB. >> Account payable and unearned income in new business amounting 26.43 MB. 26

Content Business Overview Financial Information Strategy and Outlook Q & A 27

Strategy and Outlook New Product Highlight o New Technology Product o New Green& Environmental friendly Water Int Water Injection Intelligent 28

FVC Road Map Q1.18 … NEXT SLIDE … & plan - Operated the 2 nd branch of Hemodialysis Center. to 2021 - Purchase land in Chiang Mai province. - Capital increased to 342.79 MB. - On-line Hemodiafiltration. - Acquire Hemodialysis Center (the 3 rd branch). - Special project for discount store. - Water treatment for dental (University Hospital). 2017 - Capital in subsidiary (KTMS) increased to 40.00 MB. - Entered MOU with “Wuttisak Clinic” to acquire the business in total amount not exceeding 220 MB. 2016 - Operated Hemodialysis Center. - Operated Pneumatic Tube System. 2015 - Capital Increased to 195 MB. - Expand market to Medical Service Sector - Purchase land for new office and warehouse (BKK) 2014 Restructure Technical Service Department “Water Treatment” & “Food Equipment” 2013 29 IPO on October 29, 2013

FVC Road Map 2019 - … NEXT SLIDE … 2021 - Sale target : 916.55 MB. 2018 - Exercised the 100 HD machines (Approximate) - Local Marketing for Wuttisak Clinic. - Recognize income from improve wastewater treatment systems in state hospital amount 11.20 MB - Start with new office and warehouse ( BKK) in May. - Operated 4 th branch of Hemodialysis Center. Q2.18 - Launching Water INT.(The New Flagship) - New Local Marketing & Operation in healthcare and esthetics business. - ASEAN Medical Device Directive (AMDD ) supported by the government. Q1.18 - Entered into a franchise agreement and an assets purchase agreement of “Wuttisak Clinic” 25 branches and operate in February 2018. 30